HealthMarch 30, 2021

The balancing act: COVID-19, interim guidance, and compounding best practice

A year into the pandemic response, pharmacy leaders know to expect the unexpected.

The day-to-day challenges often take us beyond the guardrails of compliance and slow progress towards best practice. In this webinar, join Wolters Kluwer compliance expert Annie Lambert, PharmD, BCSCP to discuss some key points of focus to help you maintain your balance in the unsteady world of COVID-19, interim guidance, and the impacts to your compounding practice.

You will learn:

  1. Key criteria of USP and FDA interim compounding guidance to ensure compliance.
  2. The impacts of interim guidance and COVID-19 to pharmacy operations and strategies to mitigate them.
  3. Best practices in sterile and HD compounding oversight to ensure your site is inspection-ready in a pandemic world.

Access the on-demand webinar

Annie Lambert
Clinical Program Manager for Compliance Solutions
Compliance Solution Clinical Program Manager Annie Lambert, PharmD, BCSCP is committed to providing up-to-date USP content and expert compliance guidance, and to work with you to optimize the use of our Simplifi+ pharmacy compliance solutions.
Simplifi 797®

Take the guesswork out of USP medication compounding compliance with a customizable, mobile, evidence-based solution.

Simplifi 797 provides the latest evidence-based guidance and helps navigate the complex USP Chapters 795, 797 and 800 processes to ensure inspection confidence and keep patients and staff safe.
Back To Top